BD issues €1.8B + $600M notes to fund Edwards Critical Care acquisition

BECTON DICKINSON & CO

€1.0B 3.828% notes due 2032, €800M 4.029% notes due 2036, $600M 5.081% notes due 2029 issued June 7.
Net proceeds, with commercial paper and cash, to fund cash consideration for Edwards Lifesciences Critical Care buy.
If acquisition not closed by June 3, 2025, notes subject to special mandatory redemption at 101% of par.
Proceeds not escrowed; issuances not conditioned on deal completion.
BD fully guarantees Becton Finance €800M notes; all notes are senior unsecured.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.